News & Perspective

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Nov 15, 2006

Nov 15, 2006

'Gene chip' test could speed H5N1 diagnosis

(CIDRAP News) – Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.

Dec 29, 2006

Dec 29, 2006

Feds detail progress on pandemic preparedness

(CIDRAP News) – In a recent update on pandemic influenza preparedness planning, the US government reported meeting more than 90% of a long list of objectives it set for itself about 6 months ago.

The report charts progress on a wide range of preparedness measures, from shoring up laboratory capabilities to planning for distribution of critical medical supplies and preparing checklists for various sectors of the economy.

Feb 23, 2007

Feb 23, 2007

APHA offers plan for boosting pandemic preparedness

(CIDRAP News) – The nation's largest public health group, the American Public Health Association (APHA), yesterday released recommendations aimed at strengthening existing federal strategies for pandemic preparedness and encouraging local officials and businesses to play key roles.

Feb 27, 2007

Feb 27, 2007

FDA panel supports H5N1 vaccine approval

(CIDRAP News) – A US Food and Drug Administration (FDA) panel today recommended that the agency approve the nation's first H5N1 influenza vaccine, despite new evidence that the vaccine is less protective than reported in a clinical trial last year.

Mar 06, 2007

Mar 06, 2007

Glaxo H5N1 vaccine may work against multiple strains

Editor's note: This story was revised Mar 7 to clarify information about global influenza vaccine production capacity.

Mar 14, 2007

Mar 14, 2007

FDA unveils pandemic preparedness plan

(CIDRAP News) – The US Food and Drug Administration (FDA) today issued a pandemic influenza preparedness plan that defines the agency's current role in federal pandemic planning, such as expediting the review of new vaccines and antivirals, and spells out work it will do in areas such as food safety and targeting counterfeit drugs.

Apr 17, 2007

Apr 17, 2007

FDA approves first H5N1 vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) today approved the nation's first H5N1 influenza vaccine, made by Sanofi Pasteur, which federal officials hope will buy some time to develop a more precisely targeted vaccine if the virus evolves into a pandemic strain.

Apr 27, 2007

Apr 27, 2007

Panel supports EU approval of cell-based flu vaccine

(CIDRAP News) – A committee that reviews medical product applications for the European Union (EU) yesterday recommended approval of a cell-based seasonal influenza vaccine made by Novartis, improving the company's chance of becoming the first to market a flu vaccine grown in cell culture instead of in eggs.

May 03, 2007

May 03, 2007

CDC offers advice on citizen use of masks, respirators

(CIDRAP News) – Though there is little scientific evidence to go on, wearing a surgical face mask may make sense for people who have to go into crowded public places during an influenza pandemic, federal health officials said today.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»